Network intelligence

Verge aims to map and drug the molecular networks causing neurological diseases

Verge Genomics Inc. has a machine learning platform, data trove and in-house wet lab geared for finding master regulators of complex neurological disease networks that traditional target-hunting approaches miss. The platform has already generated targets and compounds for its lead indication, amyotrophic lateral sclerosis, and netted the newco two pharma partners.

“The traditional pharmaceutical tools are simply not enough to crack the code on neurological diseases,” said

Read the full 663 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE